Looking for Zinc Stearate Excipient pharmaceutical excipients? Find information on Zinc Stearate Excipient's applications, manufacturers, suppliers, etc. on PharmaCompass.

PharmaCompass

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Octadecanoic acid zinc salt
Zinc stearate is a white, hydrophobic powder with a slight, characteristic odor. Mp: 130°C. Density: 1.1 g cm-3. Insoluble in water, ethyl alcohol and diethyl ether. Soluble in acids. Non-toxic. In technical grades, the percentage of zinc may vary according to the intended use. Products with less than the theoretical amount of zinc are more acidic.

FINISHED DOSAGE FORMULATIONS

Upload your portfolio for free, ask us

FDF DOSSIERS SUPPLIERS

read-more
read-more

01

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

SEVELAMER CARBONATE

Drug : RENVELA

Dosage Form : TABLET; ORAL

Application Number : 22127

Country : US

Patented : Yes

Sanofi Company Banner

02

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

SEVELAMER CARBONATE

Drug : SEVELAMER CARBONATE

Dosage Form : TABLET; ORAL

Application Number : 206094

Country : US

Patented : No

Dr Reddy Company Banner

03

arrow
Boulder Peptide 2024
Not Confirmed
U.S.A
arrow
Boulder Peptide 2024
Not Confirmed

NEVIRAPINE

Drug : NEVIRAPINE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 204621

Country : US

Patented : No

blank

04

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

SEVELAMER CARBONATE

Drug : SEVELAMER CARBONATE

Dosage Form : TABLET; ORAL

Application Number : 207288

Country : US

Patented : No

blank

05

arrow
Boulder Peptide 2024
Not Confirmed
Canada
arrow
Boulder Peptide 2024
Not Confirmed

BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

Drug : BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Dosage Form : TABLET; ORAL

Application Number : 78794

Country : US

Patented : No

blank

06

arrow
Boulder Peptide 2024
Not Confirmed
Canada
arrow
Boulder Peptide 2024
Not Confirmed

MOEXIPRIL HYDROCHLORIDE

Drug : MOEXIPRIL HYDROCHLORIDE

Dosage Form : TABLET; ORAL

Application Number : 78454

Country : US

Patented : No

blank

07

arrow
Boulder Peptide 2024
Not Confirmed
Canada
arrow
Boulder Peptide 2024
Not Confirmed

FOSINOPRIL SODIUM

Drug : FOSINOPRIL SODIUM

Dosage Form : TABLET; ORAL

Application Number : 76906

Country : US

Patented : No

blank

08

arrow
Boulder Peptide 2024
Not Confirmed
Canada
arrow
Boulder Peptide 2024
Not Confirmed

CLOPIDOGREL BISULFATE

Drug : CLOPIDOGREL BISULFATE

Dosage Form : TABLET; ORAL

Application Number : 76274

Country : US

Patented : No

blank

09

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

DESLORATADINE

Drug : DESLORATADINE

Dosage Form : TABLET; ORAL

Application Number : 78355

Country : US

Patented : No

blank

10

arrow
Boulder Peptide 2024
Not Confirmed
U.S.A
arrow
Boulder Peptide 2024
Not Confirmed

FOSINOPRIL SODIUM

Drug : FOSINOPRIL SODIUM

Dosage Form : TABLET; ORAL

Application Number : 76483

Country : US

Patented : No

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EXCIPIENTS BY APPLICATIONS

Click here to find the perfect excipient manufacturers by their capabilities
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty